BETRF Projected Dividend Yield
BetterLife Pharma Inc ( OTCBB : BETRF )BetterLife Pharma is a biopharmaceutical company engaged in the development and commercialization of pharmaceuticals. Co. focuses on two compounds, BETR-001 and BETR-002, for treating neuropsychiatric and neurological disorders. BETR-001, a non-hallucinogenic LSD derivative, is in preclinical and IND-enabling studies and can be self-administered due to its unregulated status. Patents cover its synthesis, composition and uses for treating depressive disorder, anxiety, and neuropathic pain. BETR-002, based on honokiol from magnolia bark, is also in preclinical and IND-enabling studies, with pending patents for treating anxiety-related disorders, including benzodiazepine dependency. 20 YEAR PERFORMANCE RESULTS |
BETRF Dividend History Detail BETRF Dividend News BETRF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |